Semaglutide

Category: GLP-1 receptor agonist

Studied or approved for: Type 2 diabetes (Ozempic), chronic weight management (Wegovy)

Regulatory status: FDA-APPROVED (brand-name products). Compounded versions are NOT FDA-approved.

Typical administration: Weekly injection (oral tablet form also exists as Rybelsus)

Educational purposes only — not medical advice. Peptiverse.net does not sell or prescribe peptides. Consult a qualified healthcare professional. Full disclaimer: /disclaimer/.